Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1502 Cn-716
Novel Zika virus (ZIKV) NS2B-NS3pro protease inhibitor
More description
DCC1501 Cn14_17
Novel Potent Inhibitor of the HIV-1 Nucleocapsid Protein
More description
DCC1500 Cmx521
Novel Inhibitor for RNA-Dependent RNA Polymerase of Norovirus
More description
DCC1499 Cmx020
Novel TRPV1 modulator, also modulating both CB1 and CB2 receptors
More description
DCC1498 Cmpi Hydrochloride
Selective and potent potentiator of nAChRs containing an α4
More description
DCC1497 Cmpd-15pa
Novel allosteric modulator of the β2 adrenergic receptor (β2AR), binding to a pocket formed primarily by the cytoplasmic ends of transmembrane segments 1, 2, 6 and 7 as well as intracellular loop 1 and helix 8
More description
DCC1496 cmpd 339509
Inhibitor of DprE1, an epimerase required for cell wall biosynthesis
More description
DCC1495 Cmi-392
Potent dual 5-lipoxygenase (5-LOX) inhibitor and platelet-activating factor (PAF) receptor antagonist
More description
DCC1494 Cm-ff-h
Novel SARS-CoV Mpro inhibitor which has its P1-phenylalanine residue bound to the relatively hydrophilic S1 pocket of the enzyme and yet exhibits a high inhibitory activity against SARS-CoV Mpro, with Ki = 2.24 ± 0.58 μM
More description
DCC1493 Cmd178 Tfa Salt
Novel peptide STAT5 inhibitor, blocking IL-2/sIL-2Rα signaling and inhibiting T reg cell development
More description
DCC1492 Cmcofx1
Novel ultrapotent and selective inhibitor of of human β-Factor XIIa
More description
DCC1491 Cmb4563
Novel Potent and Specific Target Of Rapamycin Complex 2 (TORC2) Inhibitor
More description
DCC1490 Cmap-7
Novel Hedgehog pathway inhibitor, revealing the receptor GPR39
More description
DCC1489 cm-9-78
Novel inhibitor of
More description
DCC1488 Cm-444
Novel Epigenetic Inhibitor Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma
More description
DCC1487 Cm-407
First-in-class dual PDE5 and HDAC6-selective inhibitor
More description
DCC1486 Cm-352
Novel Matrix Metalloproteinase Inhibitor As a Potent Antihemorrhagic Agent
More description
DCC1485 Cm-157
Novel selective agonist of cannabinoid CB2 receptors
More description
DCC1484 Cm-118
Novel potent and selective dual inhibitor of c-Met and ALK, potently abrogating hepatocyte growth factor (HGF)-induced c-Met phosphorylation and cell migration, phosphorylation of ALK, EML4-ALK, and ALK resistance mutants in transfected cells
More description
DCC1483 cm-10-18
Novel inhibitor of
More description
DCC1482 Cls405
Novel chromophore-linked metallo-β-lactamase (MBL) substrate as potential inhibitor against a panel of clinically relevant MBLs
More description
DCC1481 Clr1404
Precursor for tumor selective PET imaging (124I-CLR1404) or therapeutic radiation (131I-CLR1404)
More description
DCC1480 Clotiazepam
Full agonist of GABAA receptors, acting as anxiolytic, sedative, hypnotic, amnesic, anticonvulsant and muscle relaxant agent
More description
DCC1479 Clorazepate Dipotassium
Long-acting benzodiazepine, producing the active metabolite desmethyl-diazepam, which is a partial agonist of the GABAA receptor
More description
DCC1478 Cloquintocet
Herbicide safener that is added to various herbicide formulations to reduce crop damage
More description
DCC1477 Clofibride
Hypolipaemic agent, reducing hypertriglyceridemia and hypercholesterolemia
More description
DCC1476 Clobetasol
Corticosteroid Hormone Receptor Agonist
More description
DCC1475 Cl-nio Dihydrochloride
Novel inhibitor of the human enzyme dimethylarginine dimethylaminohydrolase-1 (DDAH-1)
More description
DCC1474 Clk1/2-in-3
Potent and selective CLK1 and CLK2 inhibitor
More description
DCC1473 Clk1/2-in-1
Potent CLK1 and CLK2 inhibitor, also inhibiting SRPK1 and SRPK2
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X